Science
Mechanism of Action
This ingredient operates through a dual-action mechanism. The Chironomid-derived polypeptides leverage the organism's natural desiccation tolerance (anhydrobiosis) by potentially promoting the synthesis of protective molecules such as trehalose, Late Embryogenesis Abundant (LEA) proteins, heat shock proteins, and antioxidant enzymes within skin cells. These elements work to fortify the skin barrier, safeguard against dehydration and oxidative stress, and regulate water balance via aquaporins. Concurrently, Silkworm-derived neuropeptides, exemplified by Orcokinin, are believed to function as pigmentation inhibitors and contribute to a healthier skin matrix by improving moisture retention, balancing oil production, reducing the appearance of fine lines, enhancing skin radiance, and minimizing pore visibility, alongside a potential reduction in pigment depth.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Safety
Safety Profile
Formal safety assessments by major regulatory bodies such as CIR, SCCS, or FDA specifically for SILKWORM R-SLEEPING CHIRONOMID POLYPEPTIDE-1/R-SLEEPING CHIRONOMID POLYPEPTIDE-2 have not been published. While broader categories like 'silk proteins' have undergone CIR review, specific data for this complex is absent.
Your Skin
Skin Compatibility
Our Assessment
Verdict
This innovative polypeptide complex shows promising multi-functional benefits for skin hydration, protection, and overall improvement, though specific clinical data on the combined ingredient is currently not available.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources